Correlation Between Bio Techne and Amgen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Techne and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Techne and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Techne and Amgen Inc, you can compare the effects of market volatilities on Bio Techne and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Techne with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Techne and Amgen.

Diversification Opportunities for Bio Techne and Amgen

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bio and Amgen is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Bio Techne and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Bio Techne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Techne are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Bio Techne i.e., Bio Techne and Amgen go up and down completely randomly.

Pair Corralation between Bio Techne and Amgen

Assuming the 90 days trading horizon Bio Techne is expected to under-perform the Amgen. But the stock apears to be less risky and, when comparing its historical volatility, Bio Techne is 3.14 times less risky than Amgen. The stock trades about -0.3 of its potential returns per unit of risk. The Amgen Inc is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  5,704  in Amgen Inc on December 30, 2024 and sell it today you would earn a total of  612.00  from holding Amgen Inc or generate 10.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.39%
ValuesDaily Returns

Bio Techne  vs.  Amgen Inc

 Performance 
       Timeline  
Bio Techne 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bio Techne has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Amgen Inc 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Amgen sustained solid returns over the last few months and may actually be approaching a breakup point.

Bio Techne and Amgen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Techne and Amgen

The main advantage of trading using opposite Bio Techne and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Techne position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.
The idea behind Bio Techne and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges